unsaturated fatty acid/krabbamein

Krækjan er vistuð á klemmuspjaldið

Veldu tegund tegund

13 niðurstöður

Method of treating human breast cancer by administration of radiolabeled antibody and unsaturated fatty acids

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

TECHNICAL FIELD This invention relates to a method for enhancing existing cancer therapies by additionally administering unsaturated fatty acids to a patient. More particularly, this invention relates to a method for enhancing existing breast cancer therapies such as surgery, chemo-, hormone- and

Dioxolane derivates for the treatment of cancer

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

This application is a 35 U.S.C. .sctn.371 of International Application No. PCT/NO2006/000469, filed Dec. 7, 2006, which claims the benefit of Norwegian patent application no. 20055841, filed Dec. 8, 2005, all of which are incorporated by reference herein. FIELD OF INVENTION This invention relates to

Method for treating cancer

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

This application is based upon and claims the benefit of priority from the prior Japanese Patent Application No. 11-051397, filed Feb. 26, 1999, the entire contents of which are incorporated herein by reference. BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a

Anti-tumor pharmaceutical composition comprising N-vanillyl fatty acid amide

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

FIELD OF THE INVENTION The present invention relates to an anti-tumor pharmaceutical composition. In particular, the present invention relates to an anti-tumor pharmaceutical composition having an antiproliferative effect on melanoma cells and leukemia cells. BACKGROUND OF THE INVENTION Recently,

Anticancer conjugates of camptothecin and unsaturated fatty acids

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

FIELD OF THE INVENTION The present invention relates to novel fatty acid derivatives of the camptothecin class of compounds, their methods of preparation and use as antitumor agents. BACKGROUND OF THE INVENTION Cancer cells do not contain molecular targets that are completely foreign to the host.

Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

FIELD OF INVENTION The present invention relates to certain unsaturated fatty acid derivatives of therapeutically active glucocorticoides and pharmaceutical formulations containing them. The said derivatives are referred to as "Compounds of formula (I)" in the present specification and claims.

Therapeutic liposome and method of treating a subject having cancer

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

BACKGROUND OF THE INVENTION Technical Field The present invention relates to a liposome for treating cancer by including doxorubicin, a polyunsaturated fatty acid, and beta glucan in combination. Description of the Related Art The "background" description provided herein is for the purpose of

Fads regulation

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

FIELD OF INVENTION The present invention relates to the field of modulation of fatty acid desaturases (FADS) expression and the application thereof in disease treatment. BACKGROUND The delta-5 and delta-6 desaturases (encoded by FADS1 and FADS2, respectively) are essential for biosynthesis of

Methods and compositions for inhibiting 5.alpha.-reductase activity

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to compounds, compositions and methods regulating the actions of androgens and other steroid hormones by modulating the activity of 5.alpha.-reductase. More particularly, the present invention relates to

TGF-B compositions and method

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

BACKGROUND Human TGF-beta has been isolated from human blood platelets and placenta and purified to essential homogeneity using sequential gel filtration cation-exchange chromatography and high performance liquid chromatography (HPLC). The purified protein was characterized as having a molecular

Method of stabilizing and potentiating the action of anti-angiogenic substances

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

FIELD OF THE INVENTION The present invention generally relates to the use of anti-angiogenic agents in the cure of cell proliferative disorders including cancer and other disorders caused by uncontrolled angiogenic activity in the body. More particularly, the invention is directed to the efficacious

Method of stabilizing and potentiating the action of anti-angiogenic substances

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Method of stabilizing and potentiating the action of anti-angiogenic substances

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Skráðu þig á
facebook síðu okkar

Herbal & Natural Medicine

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

Virkar á 55 tungumálum
Jurtalækningar studdir af vísindum
Jurtaviðurkenning eftir ímynd
Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
Lestu vísindarit sem tengjast leit þinni
Leitaðu að lækningajurtum eftir áhrifum þeirra
Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum